New weight loss drugs could mean a $25 billion drag on restaurants by 2025, says Mizuho’s Dan Dolev

Dan Dolev, Senior Analyst US Technology – Payments, Processors & Business Services at Mizuho Securities, joins ‘The Exchange’ to discuss how new weight loss drugs could decrease revenue for restaurant transaction platform Toast.